Did you know that there are currently 38 clinical studies and researches being carried out at Pantai Hospital Kuala Lumpur to improve quality of care and clinical outcomes? These are driven by none other than Malaysia Operation’s first Research & Innovation Department set up in November last year.
Senior Research Scientist Dr Wong Shin Yee, a PhD holder in Molecular Medicine, heads the new department, supported by a team of experienced study coordinators and research assistants. For months now, they have been working with different stakeholders on the 38 approved studies that span multiple medical fields.
Cancer therapy is the current research focus, with 14 oncology clinical trials underway relating to breast cancer and non-small cell lung carcinoma. In addition, there are five oncology studies initiated by the consultants at Pantai Hospital Kuala Lumpur to determine the clinical outcomes of cancer patients at Pantai Hospital Kuala Lumpur.
The team is making good headway and looks forward to share their research outcomes soon. Stay tuned.
Related Stories
-marks-nation-s-historic-first-in-early-stage-oesophageal-cancer-treatment.png?sfvrsn=4932c57_1)
Pantai Hospital Kuala Lumpur Performs Nation’s First Early-stage Oesophageal Cancer Treatment
Pantai Hospital Kuala Lumpur has achieved a historic milestone in gastrointestinal care, successfully performing Malaysia's first 360-degree circumferential Endoscopic Submucosal Dissection (ESD) for early-stage oesophageal cancer.
Parkway Rehab Champions Care Without Barriers
At IHH Healthcare Singapore, care doesn’t stop at the clinic doors. We believe healthcare should be accessible, especially for those who face barriers in receiving it.
Parkway Radiology Reopens Upgraded Nuclear Medicine and PET Centre at Mount Elizabeth Hospital
Parkway Radiology’s Nuclear Medicine and PET Centre at Mount Elizabeth Hospital has officially reopened following a comprehensive renovation, offering an enhanced patient experience within a modern and welcoming environment.
Fortis Achieves Stronger ESG Rating and Rises to #2 Among Healthcare Peers
Fortis Healthcare has received its latest ESG rating from the National Stock Exchange, and we are pleased to share significant progress in both our score and sector ranking.
Gleneagles Hospital Hong Kong Advances Regional Collaboration in Venous Disease Care
Gleneagles Hospital Hong Kong, part of the IHH Healthcare network, has entered into a strategic partnership with the Asian Venous Academy and Dr Smile Medical Group to advance collaboration in venous disease related services, research and education.
IHH Singapore and Medistra Hospital Sign MoU to Strengthen Liver Disease Care in the Region
IHH Healthcare Singapore and Medistra Hospital signed a Memorandum of Understanding (MoU) on 22 January 2026, marking a significant step forward in advancing liver disease services and strengthening healthcare quality across the region.
